Tapewire

Nasdaq · USD

VCEL

Vericel Corp

Export transactions ↓
Tapewire entity
4481
SEC CIK
0000887359
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 34 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202601
Feb 202601
Mar 202604
Apr 202601
May 202607
Jun 202609
Jul 202603
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 18, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 17, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $51.55 $902,125.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,937

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 17, 2024 Filed Jul 19, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 16, 2024 Filed Jul 18, 2024 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-24-033484 · form4.xml · derivative · entry 3

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 15,000 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
July 16, 2024 Filed Jul 18, 2024 20:05 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 15,000 $52.18 $782,700.00
Disclosure

SEC source: 0001140361-24-033484 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 707

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 16, 2024 Filed Jul 18, 2024 20:05 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 15,000 $16.25 $243,750.00
Disclosure

SEC source: 0001140361-24-033484 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 12, 2024 Filed Jul 16, 2024 20:05 UTC
Mara Joseph Anthony JrChief Financial Officer
SaleCommon Stock 5,000 $50.00 $250,000.00
Disclosure

SEC source: 0001140361-24-033292 · form4.xml · nonDerivative · entry 1

Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,436

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 05, 2024 Filed Jul 9, 2024 20:05 UTC
SIEGAL JONATHANPrincipal Accounting Officer
SaleCommon Stock 545 $45.00 $24,525.00
Disclosure

SEC source: 0001140361-24-032762 · form4.xml · nonDerivative · entry 1

SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,033

F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 30, 2024 Filed Feb 13, 2025 21:05 UTC
Halpin MichaelChief Operating Officer
GrantCommon Stock 95 $39.00 $3,705.00
Disclosure

SEC source: 0001140361-25-004301 · form5.xml · nonDerivative · entry 1

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,379

F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 24, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,474 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · derivative · entry 9

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 1,474 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 24, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 1,474 $45.84 $67,568.16
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 6

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 487

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 24, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 1,474 $16.25 $23,952.50
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 5

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,772 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · derivative · entry 8

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,474

Underlying: Common Stock · 6,772 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 6,772 $45.02 $304,875.44
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 4

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 487

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 6,772 $16.25 $110,045.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 3

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,754 $0.00 Strike: $16.25 $0.00
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · derivative · entry 7

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,246

Underlying: Common Stock · 6,754 shares

Expires 2029-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
SaleCommon Stock 6,754 $45.04 $304,200.16
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 2

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 487

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 20, 2024 Filed Jun 24, 2024 22:21 UTC
Flynn Sean C.Chief Legal Officer
Exercise / conversionCommon Stock 6,754 $16.25 $109,752.50
Disclosure

SEC source: 0001140361-24-031149 · form4.xml · nonDerivative · entry 1

Flynn Sean C. · CIK 0001801993 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,241

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 13, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · derivative · entry 6

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
June 13, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $43.10 $754,250.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 4

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,752

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 13, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $44.12 $772,100.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,752

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-030179 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:05 UTC
WRIGHT LISADirector
Exercise / conversionRestricted Stock Unit · Derivative 434 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-029005 · form4.xml · derivative · entry 2

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F3 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:05 UTC
WRIGHT LISADirector
Exercise / conversionCommon Stock 434 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-029005 · form4.xml · nonDerivative · entry 1

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021.

Read SEC document
May 20, 2024 Filed May 21, 2024 20:07 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $10.95 $0.00
Disclosure

SEC source: 0001140361-24-027027 · form4.xml · derivative · entry 3

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,604

Underlying: Common Stock · 10,000 shares

Expires 2028-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
May 20, 2024 Filed May 21, 2024 20:07 UTC
Hopper Jonathan MarkChief Medical Officer
SaleCommon Stock 10,000 $49.99 $499,900.00
Disclosure

SEC source: 0001140361-24-027027 · form4.xml · nonDerivative · entry 2

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,116

F2 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 20, 2024 Filed May 21, 2024 20:07 UTC
Hopper Jonathan MarkChief Medical Officer
Exercise / conversionCommon Stock 10,000 $10.95 $109,500.00
Disclosure

SEC source: 0001140361-24-027027 · form4.xml · nonDerivative · entry 1

Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 17, 2024 Filed May 21, 2024 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,132 $0.00 Strike: $7.20 $0.00
Disclosure

SEC source: 0001140361-24-027025 · form4.xml · derivative · entry 4

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,132 shares

Expires 2028-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options, representing the right to purchase 40,330 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,063 $0.00 Strike: $2.65 $0.00
Disclosure

SEC source: 0001140361-24-027025 · form4.xml · derivative · entry 3

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,063 shares

Expires 2027-04-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionCommon Stock 3,132 $7.20 $22,550.40
Disclosure

SEC source: 0001140361-24-027025 · form4.xml · nonDerivative · entry 2

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 17, 2024 Filed May 21, 2024 20:05 UTC
Halpin MichaelChief Operating Officer
Exercise / conversionCommon Stock 2,063 $2.65 $5,466.95
Disclosure

SEC source: 0001140361-24-027025 · form4.xml · nonDerivative · entry 1

Halpin Michael · CIK 0001778858 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time.

F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 16, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · derivative · entry 6

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,000

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $47.85 $837,375.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 4

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,752

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 16, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 3

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 15, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · derivative · entry 5

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,500

Underlying: Common Stock · 17,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.

F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025.

Read SEC document
May 15, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
SaleCommon Stock 17,500 $49.67 $869,225.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 2

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,752

F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 15, 2024 Filed May 17, 2024 20:05 UTC
Colangelo DominickDirector · President and CEO
Exercise / conversionCommon Stock 17,500 $3.02 $52,850.00
Disclosure

SEC source: 0001140361-24-026682 · form4.xml · nonDerivative · entry 1

Colangelo Dominick · CIK 0001313403 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC
WRIGHT LISADirector
GrantRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-024335 · form4.xml · derivative · entry 4

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC
WRIGHT LISADirector
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $47.08 $0.00
Disclosure

SEC source: 0001140361-24-024335 · form4.xml · derivative · entry 3

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2034-05-01

F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC
WRIGHT LISADirector
Exercise / conversionRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-024335 · form4.xml · derivative · entry 2

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC
WRIGHT LISADirector
Exercise / conversionCommon Stock 3,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-024335 · form4.xml · nonDerivative · entry 1

WRIGHT LISA · CIK 0001865017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC GrantRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-024334 · form4.xml · derivative · entry 4

ZERBE ROBERT L MD · CIK 0001220363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $47.08 $0.00
Disclosure

SEC source: 0001140361-24-024334 · form4.xml · derivative · entry 3

ZERBE ROBERT L MD · CIK 0001220363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2034-05-01

F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-024334 · form4.xml · derivative · entry 2

ZERBE ROBERT L MD · CIK 0001220363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023.

F4 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC Exercise / conversionCommon Stock 3,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-24-024334 · form4.xml · nonDerivative · entry 1

ZERBE ROBERT L MD · CIK 0001220363 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC GrantRestricted Stock Unit · Derivative 3,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-24-024333 · form4.xml · derivative · entry 4

Wotton Paul K · CIK 0001300997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,200

Underlying: Common Stock · 3,200 shares

Expires not disclosed

F2 · derivative.exercise_price: Upon the vesting of RSUs granted to the Reporting Person on May 3, 2023, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.

F7 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.

F5 · derivative.expiration_date: No expiration date for this type of award.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:06 UTC GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $47.08 $0.00
Disclosure

SEC source: 0001140361-24-024333 · form4.xml · derivative · entry 3

Wotton Paul K · CIK 0001300997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2034-05-01

F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.